Sponsor Pipeline

Shandong Boan Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
4
Recruiting
1
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
1
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT06022861 A Study to Compare the Efficacy and Safety of LY01015 and Opdivo® Combined Respectively… Esophageal Squamous Cell Carcinoma Recruiting
Phase 1
NCT05909241 A Study of BA1202 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
NCT06927349 A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of… Advanced Solid Tumours Recruiting
NCT06596915 Safety and Efficacy of BA1302 in Patients With Advanced Solid Tumors Non-Small Cell Lung Cancer Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (1) Lung Cancer (1) Breast Cancer (1) Melanoma (1)
Get alerts when Shandong Boan Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free